300 related articles for article (PubMed ID: 15273504)
41. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
Iwai K; Yamanaka K; Kamura T; Minato N; Conaway RC; Conaway JW; Klausner RD; Pause A
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12436-41. PubMed ID: 10535940
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
LaSalle JM; Reiter LT; Chamberlain SJ
Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
[TBL] [Abstract][Full Text] [Related]
43. LRSAM1 E3 ubiquitin ligase promotes proteasomal clearance of E6-AP protein.
Mishra R; Joshi V; Upadhyay A; Amanullah A; Dubey AR; Singh S; Dubey VK; Poluri KM; Jana NR; Mishra A
Cell Signal; 2021 Jan; 77():109836. PubMed ID: 33207262
[TBL] [Abstract][Full Text] [Related]
44. The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate.
Nuber U; Schwarz SE; Scheffner M
Eur J Biochem; 1998 Jun; 254(3):643-9. PubMed ID: 9688277
[TBL] [Abstract][Full Text] [Related]
45. Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination.
Wang Y; Guan S; Acharya P; Koop DR; Liu Y; Liao M; Burlingame AL; Correia MA
J Biol Chem; 2011 Mar; 286(11):9443-56. PubMed ID: 21209460
[TBL] [Abstract][Full Text] [Related]
46. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
47. Role of the ubiquitin proteasome system in hematologic malignancies.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
[TBL] [Abstract][Full Text] [Related]
48. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.
Yaron A; Hatzubai A; Davis M; Lavon I; Amit S; Manning AM; Andersen JS; Mann M; Mercurio F; Ben-Neriah Y
Nature; 1998 Dec; 396(6711):590-4. PubMed ID: 9859996
[TBL] [Abstract][Full Text] [Related]
49. Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system.
Shkedy D; Gonen H; Bercovich B; Ciechanover A
FEBS Lett; 1994 Jul; 348(2):126-30. PubMed ID: 8034027
[TBL] [Abstract][Full Text] [Related]
50. Substrate properties of ubiquitin carboxyl-terminally derived peptide probes for protein ubiquitination.
Madden MM; Song W; Martell PG; Ren Y; Feng J; Lin Q
Biochemistry; 2008 Mar; 47(12):3636-44. PubMed ID: 18307316
[TBL] [Abstract][Full Text] [Related]
51. Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays.
Andrews PS; Schneider S; Yang E; Michaels M; Chen H; Tang J; Emkey R
Assay Drug Dev Technol; 2010 Aug; 8(4):471-87. PubMed ID: 20804422
[TBL] [Abstract][Full Text] [Related]
52. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.
Scheffner M; Huibregtse JM; Howley PM
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8797-801. PubMed ID: 8090726
[TBL] [Abstract][Full Text] [Related]
53. Transmembrane Protein pUL50 of Human Cytomegalovirus Inhibits ISGylation by Downregulating UBE1L.
Lee MK; Kim YJ; Kim YE; Han TH; Milbradt J; Marschall M; Ahn JH
J Virol; 2018 Aug; 92(15):. PubMed ID: 29743376
[TBL] [Abstract][Full Text] [Related]
54. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
55. Unstructured Biology of Proteins from Ubiquitin-Proteasome System: Roles in Cancer and Neurodegenerative Diseases.
Gadhave K; Kumar P; Kapuganti SK; Uversky VN; Giri R
Biomolecules; 2020 May; 10(5):. PubMed ID: 32455657
[TBL] [Abstract][Full Text] [Related]
56. Protein Ubiquitination Assay.
Wei P; Liang R; Pan F
Methods Mol Biol; 2023; 2559():137-149. PubMed ID: 36180631
[TBL] [Abstract][Full Text] [Related]
57. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system.
Akinjiyan FA; Carbonneau S; Ross NT
Bioorg Med Chem Lett; 2017 Oct; 27(20):4589-4596. PubMed ID: 28911816
[TBL] [Abstract][Full Text] [Related]
58. Simulation and Computational Study of RING Domain Mutants of BRCA1 and Ube2k in AD/PD Pathophysiology.
Sahu M; Rani N; Kumar P
Mol Biotechnol; 2024 May; 66(5):1095-1115. PubMed ID: 38172369
[TBL] [Abstract][Full Text] [Related]
59. Expanding the ubiquitin code in pancreatic cancer.
Yang W; Wang S; Tong S; Zhang WD; Qin JJ
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166884. PubMed ID: 37704111
[TBL] [Abstract][Full Text] [Related]
60. The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases.
Celebi G; Kesim H; Ozer E; Kutlu O
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
